This page includes the latest FDA filings for Esperion Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | ESPR | DUNS 029516312 |
Device Company | Device | Date |
---|---|---|
Esperion Therapeutics, Inc. | Prescription Medication | 2024-12-07 |
Esperion Therapeutics, Inc. | Prescription Medication | 2024-12-07 |
Esperion Therapeutics, Inc. | Prescription Medication | 2024-10-19 |
Esperion Therapeutics, Inc. | Prescription Medication | 2024-10-19 |
Esperion Therapeutics, Inc. | Prescription Medication | 2024-06-08 |
Esperion Therapeutics, Inc. | Prescription Medication | 2024-04-03 |
Esperion Therapeutics, Inc. | Prescription Medication | 2024-04-03 |
Esperion Therapeutics, Inc. | Prescription Medication | 2023-12-16 |
Esperion Therapeutics, Inc. | Prescription Medication | 2023-12-16 |
Esperion Therapeutics, Inc. | Prescription Medication | 2023-09-28 |
Esperion Therapeutics, Inc. | Prescription Medication | 2023-09-28 |
Esperion Therapeutics, Inc. | Prescription Medication | 2023-09-13 |
Esperion Therapeutics, Inc. | Prescription Medication | 2023-09-08 |
Esperion Therapeutics, Inc. | Prescription Medication | 2023-06-28 |
Esperion Therapeutics, Inc. | Prescription Medication | 2023-06-28 |
Esperion Therapeutics, Inc. | Prescription Medication | 2022-10-12 |
Esperion Therapeutics, Inc. | Prescription Medication | 2022-10-09 |
Esperion Therapeutics, Inc. | Prescription Medication | 2021-10-02 |
Esperion Therapeutics, Inc. | Prescription Medication | 2021-10-02 |
Esperion Therapeutics, Inc. | Prescription Medication | 2020-11-13 |
Esperion Therapeutics, Inc. | Prescription Medication | 2020-11-06 |
Esperion Therapeutics, Inc. | Prescription Medication | 2020-03-14 |
Esperion Therapeutics, Inc. | Prescription Medication | 2020-03-11 |
Esperion Therapeutics, Inc. | Nexlizet | 2020-03-09 |
Esperion Therapeutics, Inc. | Nexletol | 2020-03-06 |
Esperion Therapeutics, Inc. | Prescription Medication | 2020-03-06 |
NCAGE Code | 62GZ9 | ESPERION THERAPEUTICS INC |
CAGE Code | 62GZ9 | ESPERION THERAPEUTICS, INC. ESPERION |
SEC | 0001434868 | Esperion Therapeutics, Inc. of DELAWARE |